Back
Adverum Biotechnologies Vs. Hims & Hers Health Industry Stock Comparison
Sell
32
ADVM
Adverum Biotechnologies
Last Price:
$4.46
Seasonality Move:
-8.02%
Buy
75
HIMS
Hims & Hers Health
Last Price:
$60.50
Seasonality Move:
-9.4%
Sell
32
Adverum Biotechnologies (ADVM)
is a Sell
Is Adverum Biotechnologies a Buy, Sell or Hold?
-
The current Adverum Biotechnologies [ADVM] share price is $4.46. The Score for ADVM is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
-
ADVM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
75
Hims & Hers Health (HIMS)
is a Buy
Is Hims & Hers Health a Buy, Sell or Hold?
-
The current Hims & Hers Health [HIMS] share price is $60.47. The Score for HIMS is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
-
HIMS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ADVM Stock Price Chart
What is Adverum Biotechnologies's stock price today?
-
The Adverum Biotechnologies share price today is $4.46The current trend is relatively stagnant and ADVM is experiencing buying pressure, which is a positive indicator for future bullish movement.
HIMS Stock Price Chart
What is Hims & Hers Health's stock price today?
-
The Hims & Hers Health share price today is $60.47Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HIMS is experiencing slight selling pressure.
ADVM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.15 | Sell |
| Relative Strength Index (14 RSI): | 49.09 | Sell |
| Chaikin Money Flow: | 69268 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.21 - 4.53) | Buy |
| Bollinger Bands (100): | (4.64 - 7.46) | Sell |
HIMS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.57 | Buy |
| Relative Strength Index (14 RSI): | 87.68 | Buy |
| Chaikin Money Flow: | -15624062 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.88 - 45.76) | Buy |
| Bollinger Bands (100): | (19 - 35.5) | Buy |
ADVM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.31 | Buy |
| 20-day SMA: | 4.38 | Buy |
| 50-day SMA: | 4.79 | Sell |
| 200-day SMA: | 6.85 | Sell |
| 8-day EMA: | 4.31 | Buy |
| 20-day EMA: | 4.4 | Buy |
| 50-day EMA: | 4.91 | Sell |
| 200-day EMA: | 7.11 | Sell |
HIMS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.45 | Buy |
| 20-day SMA: | 38.73 | Buy |
| 50-day SMA: | 32.59 | Buy |
| 200-day SMA: | 22.63 | Buy |
| 8-day EMA: | 49.17 | Buy |
| 20-day EMA: | 41.38 | Buy |
| 50-day EMA: | 34.24 | Buy |
| 200-day EMA: | 24.01 | Buy |
Adverum Biotechnologies Earnings Growth & ADVM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.70 per share, and an increase next year of $0.53 per share.
Hims & Hers Health Earnings Growth & HIMS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and an increase next year of $0.12 per share.
Adverum Biotechnologies Technical Analysis
| Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Hims & Hers Health Technical Analysis
| Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||